Igor Gonda, PhD, is the Founder of Respidex, a San Francisco-based consulting company. Dr Gonda has held a variety of executive positions in US and Australian private and public pharmaceutical and biotech companies.

His research focus has been primarily in the area of drugs and biologics administered to the lung and nose conducted in industry and, prior to that, in universities in England, Australia and the US.

Dr Gonda’s current interests additionally include the pevention and cure of  the COVID19 respiratory infection; involvement of patient advocacy groups in pharmaceutical R&D; venture philanthropy and the regulatory process to accelerate availability of cures for their diseases, and in opportunities for making individualised precision medicines faster and cheaper.

More contributions